Shu Ren

Callaghan, NSW, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Prevention of Adverse Cardiovascular Events Using the 23-Valent Pneumococcal Polysaccharide Vaccine: A Randomized Clinical Trial.

Prevention of Adverse Cardiovascular Events Using the 23-Valent Pneumococcal Polysaccharide Vaccine: A Randomized Clinical Trial.

Journal: JAMA cardiology
Published: September 17, 2025

External Validation of the 2023 Australian Cardiovascular Risk Calculator.

External Validation of the 2023 Australian Cardiovascular Risk Calculator.

Journal: Heart, lung & circulation
Published: November 27, 2024

Persistence of Detectable Anti-Pneumococcal Antibodies 4 Years After Pneumococcal Polysaccharide Vaccination in a Randomised Controlled Trial: The Australian Study for the Prevention through Immunisation of Cardiovascular Events (AUSPICE).

Persistence of Detectable Anti-Pneumococcal Antibodies 4 Years After Pneumococcal Polysaccharide Vaccination in a Randomised Controlled Trial: The Australian Study for the Prevention through Immunisation of Cardiovascular Events (AUSPICE).

Journal: Heart, lung & circulation
Published: June 04, 2023

Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade-resistant Melanoma for Anti-PD-L1 Rechallenge.

Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade-resistant Melanoma for Anti-PD-L1 Rechallenge.

Journal: Cancer research communications
Published: May 09, 2022

Generation of cardio-protective antibodies after pneumococcal polysaccharide vaccine: Early results from a randomised controlled trial.

Generation of cardio-protective antibodies after pneumococcal polysaccharide vaccine: Early results from a randomised controlled trial.

Journal: Atherosclerosis
Published: September 19, 2021

Pneumococcal polysaccharide vaccine is a cost saving strategy for prevention of acute coronary syndrome.

Pneumococcal polysaccharide vaccine is a cost saving strategy for prevention of acute coronary syndrome.

Journal: Vaccine
Published: June 10, 2020

Evaluating recruitment strategies for AUSPICE, a large Australian community-based randomised controlled trial.

Evaluating recruitment strategies for AUSPICE, a large Australian community-based randomised controlled trial.

Journal: The Medical journal of Australia
Published: September 15, 2018

Pneumococcal polysaccharide vaccine associated with reduced lengths of stay for cardiovascular events hospital admissions: Experience from the Hunter Community Study.

Pneumococcal polysaccharide vaccine associated with reduced lengths of stay for cardiovascular events hospital admissions: Experience from the Hunter Community Study.

Journal: Vaccine
Published: January 23, 2018

Rationale and design of a randomized controlled trial of pneumococcal polysaccharide vaccine for prevention of cardiovascular events: The Australian Study for the Prevention through Immunization of Cardiovascular Events (AUSPICE).

Rationale and design of a randomized controlled trial of pneumococcal polysaccharide vaccine for prevention of cardiovascular events: The Australian Study for the Prevention through Immunization of Cardiovascular Events (AUSPICE).

Journal: American heart journal
Published: November 08, 2015

Effect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysis.

Effect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysis.

Journal: Open heart
Published: January 24, 2015
Showing 1-10 of 10

Last Updated: 09/26/2026